Semin Thromb Hemost 2007; 33(5): 503-507
DOI: 10.1055/s-2007-982081
Copyright © 2007 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Determination of Antithrombin-Dependent Factor Xa Inhibitors by Prothrombin-Induced Clotting Time

Job Harenberg1 , Christina Giese1 , Antje Hagedorn1 , Inge Traeger1 , Tivadar Fenyvesi1
  • 1Medizinische Klinik, Universitätsklinikum Mannheim, Mannheim, Germany
Further Information

Publication History

Publication Date:
16 July 2007 (online)

Preview

ABSTRACT

Prothrombinase-induced clotting time (PiCT) determines the anticoagulant effects of heparins, low molecular weight heparins (LMWHs), and direct thrombin inhibitors. At present, this is the only method that measures the effects of all of these inhibitors, in contrast to the prothrombin time, activated partial thromboplastin time (aPTT), Heptest, ecarin clotting time, and the chromogenic assays. The antithrombin-dependent direct factor (F) Xa inhibitors fondaparinux and idraparinux were compared with the LMWH dalteparin on PiCT, aPTT, Heptest, and chromogenic anti-FXa assays in pooled human normal plasma samples. Fondaparinux and idraparinux prolonged the coagulation times in the PiCT, Heptest, and chromogenic FXa assays in a dose-dependent manner, in contrast to the aPTT. We conclude that PiCT is a suitable assay to determine the anticoagulant effects of these two new FXa inhibitors in patients receiving treatment with these compounds.

REFERENCES

Prof. Dr. med. J Harenberg

IV, Medizinische Klinik, Universitätsklinikum Mannheim

Theodor-Kutzer-Ufer, D-68167 Mannheim, Germany

Email: job.harenberg@med.ma.uni-heidelberg.de